1. Home
  2. UBX vs SHOT Comparison

UBX vs SHOT Comparison

Compare UBX & SHOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBX
  • SHOT
  • Stock Information
  • Founded
  • UBX 2009
  • SHOT 2018
  • Country
  • UBX United States
  • SHOT United States
  • Employees
  • UBX N/A
  • SHOT N/A
  • Industry
  • UBX Biotechnology: Pharmaceutical Preparations
  • SHOT Biotechnology: Pharmaceutical Preparations
  • Sector
  • UBX Health Care
  • SHOT Health Care
  • Exchange
  • UBX Nasdaq
  • SHOT Nasdaq
  • Market Cap
  • UBX 29.2M
  • SHOT 31.4M
  • IPO Year
  • UBX 2018
  • SHOT 2020
  • Fundamental
  • Price
  • UBX $2.22
  • SHOT $0.49
  • Analyst Decision
  • UBX Strong Buy
  • SHOT
  • Analyst Count
  • UBX 2
  • SHOT 0
  • Target Price
  • UBX $7.00
  • SHOT N/A
  • AVG Volume (30 Days)
  • UBX 483.8K
  • SHOT 929.4K
  • Earning Date
  • UBX 11-04-2024
  • SHOT 11-14-2024
  • Dividend Yield
  • UBX N/A
  • SHOT N/A
  • EPS Growth
  • UBX N/A
  • SHOT N/A
  • EPS
  • UBX N/A
  • SHOT N/A
  • Revenue
  • UBX N/A
  • SHOT $652,495.00
  • Revenue This Year
  • UBX N/A
  • SHOT N/A
  • Revenue Next Year
  • UBX $33.62
  • SHOT N/A
  • P/E Ratio
  • UBX N/A
  • SHOT N/A
  • Revenue Growth
  • UBX N/A
  • SHOT 68.01
  • 52 Week Low
  • UBX $0.94
  • SHOT $0.45
  • 52 Week High
  • UBX $3.10
  • SHOT $4.05
  • Technical
  • Relative Strength Index (RSI)
  • UBX 61.12
  • SHOT 31.48
  • Support Level
  • UBX $2.02
  • SHOT $0.45
  • Resistance Level
  • UBX $2.42
  • SHOT $0.57
  • Average True Range (ATR)
  • UBX 0.31
  • SHOT 0.06
  • MACD
  • UBX 0.01
  • SHOT 0.00
  • Stochastic Oscillator
  • UBX 39.61
  • SHOT 2.23

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

About SHOT Safety Shot Inc.

Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.

Share on Social Networks: